PRT-061103

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePRT-061103

Drug Alias Nameaspirin replacement therapy (Portola)thromboxane receptor antagonist (Portola)acetylsalicylic acid replacement therapy (Portola)PRT-061103

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet aggregation inhibitorsThromboxane antagonists

TargetsUpdating

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPortola Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPortola Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A